General Information of Drug (ID: DM64WYC)

Drug Name
ATX-101 Drug Info
Synonyms ATX-101, APIM Therapeutics; Proliferating cell nuclear antigen (peptide, cancer), APIM
Indication
Disease Entry ICD 11 Status REF
Obesity 5B81 Phase 3 [1]
Cross-matching ID
PubChem CID
222528
ChEBI ID
CHEBI:28834
CAS Number
CAS 83-44-3
TTD Drug ID
DM64WYC
INTEDE Drug ID
DR2468
ACDINA Drug ID
D00996

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ChelASE DM0JUAL Retina disorder 9B70-9B7Z Discontinued in Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proliferating cell nuclear antigen (PCNA) TTLG1PD PCNA_HUMAN Immunomodulator [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 610).
2 Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells. PLoS One. 2013 Jul 31;8(7):e70430.
3 Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol. 2007 Sep;125(9):1161-7.